Skip to contentR
Rockwell Medical, Inc.
R
RMTIRockwell Medical, Inc. Q3 2024 · 10-Q
Revenue$28.32M$28.32M+19.1% vs Q3 2023 Net Income$1.66M$1.66MN/M vs Q3 2023 EPS Diluted$0.04$0.04N/M vs Q3 2023 Gross Profit$6,239,000+183.3% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Rockwell Medical, Inc. · CIK 1041024 · Engraved from SEC EDGAR
Operating Cash Flowderived$4,275,000N/M Free Cash Flowderived$4,084,000— Margins · derivedGross margin22.0%+12.8 pt vs Q3 2023
Operating margin6.8%+14.1 pt vs Q3 2023
Net margin5.9%+13.8 pt vs Q3 2023
ended Sep 30, 2024 · filed Nov 12, 2024 · 43 d after period end